Updates are available Correction dated 2025-12-17
Click to view Correction: https://doi.org/10.1208/s12248-025-01189-5
-
Authors
Wojtyniak, Daniel https://orcid.org/0009-0006-4169-563X
Guk, Jinju https://orcid.org/0000-0003-3254-091X
Wicha, Sebastian G. https://orcid.org/0000-0002-8773-4845
-
Funding
Funding for this research was provided by:
Universität Hamburg
- License Information
-
More Information
Article History
Received: 30 May 2025
Accepted: 23 September 2025
First Online: 30 October 2025
Change Date: 1 December 2025
Change Type: Update
Change Details: The original version of the article has been revised to add the following reference at the following spot:
Change Details: Two recently introduced methods to control T1 in treatment-response are “Individual Model Averaging” (IMA) [7], and “randomized combined Likelihood Ratio Test-Modelling” (rcLRT-Mod) [6,ADD REF HERE].
Change Details: Buatois S, Ueckert S, Frey N, Retout S, Mentré F. cLRT‐Mod : An efficient methodology for pharmacometric model‐based analysis of longitudinal phase II dose finding studies under model uncertainty. Stat Med. 2021;40:2435–51.https://doi.org/10.1002/sim.8913.
Change Date: 17 December 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1208/s12248-025-01189-5
Declarations
:
: All authors declare that they have no conflicts of interest.
: AI technology was used for R coding assistance and for finding formulations and synonyms for the final manuscript.
